Stem cells show promise for failing livers

NCT ID NCT06242405

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether multiple infusions of stem cells from donated umbilical cords could help people with end-stage liver disease. 92 adults received the stem cells through a vein, and researchers tracked liver function and complications. The goal was to see if repeated doses work better than a single dose.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
umbilical cord mesenchymal stem cells
What this could lead to
If successful, this could point toward a way to improve liver function and reduce complications in people with end-stage liver disease, potentially delaying the need for a transplant.
What could go wrong
This is a small, completed study with 92 participants and no control group, so results may not be conclusive. Stem cell infusions carry risks like infection or immune reactions, and the long-term benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic liver failure End Stage Liver Disease Fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • General Hospital of Northern Theater Command

    Shenyang, Liaoning, 110840, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.